drugset / Trial / NCT02299414

Chronic Hypertension and Pregnancy (CHAP) Project

NCT02299414

Phase 4 Completed 2408 enrolled University of Alabama at Birmingham Arrowhead Regional Medical Center · collabBaylor College of Medicine · collabBeaumont Hospital · collabCase Western/Metro Health · collabChristiana Care Health Services · collabColumbia University · collabDenver Health and Hospital Authority · collabDrexel University College of Medicine · collabDuke Regional Hospital · collabDuke University · collabEmory University · collabGeisinger Clinic · collabGundersen Health System · collabIndiana University · collabIntermountain Health Care, Inc. · collabJohns Hopkins University · collabLatter Day Saints Hospital · collabLehigh Valley Hospital · collabLyndon B Johnson General Hospital · collabMcKay-Dee Hospital · collabMedical College of Wisconsin · collabMedical University of South Carolina · collabMeriter Foundation · collabMiami Valley Hospital · collabNational Heart, Lung, and Blood Institute (NHLBI) · collabNew Jersey Medical School · collabNew York Hospital Queens · collabNorthwestern University · collabOchsner Health System · collabOhio State University · collabOregon Health and Science University · collabRutgers, The State University of New Jersey · collabSaint Peters University Hospital · collabSan Francisco General Hospital · collabSt. Luke's Hospital and Health Network, Pennsylvania · collabStanford University · collabTemple University · collabThe Cleveland Clinic · collabThe University of Texas Health Science Center, Houston · collabThe University of Texas Medical Branch, Galveston · collabTriHealth Inc. · collabTulane University · collabUniversity of Arkansas · collabUniversity of California, San Diego · collabUniversity of California, San Francisco · collabUniversity of Colorado, Denver · collabUniversity of Iowa · collabUniversity of Kansas Medical Center · collabUniversity of North Carolina, Chapel Hill · collabUniversity of Oklahoma · collabUniversity of Pennsylvania · collabUniversity of Pittsburgh · collabUniversity of South Alabama · collabUniversity of Tennessee · collabUniversity of Texas Southwestern Medical Center · collabUniversity of Utah · collabUtah Valley Regional Medical Center · collabVanderbilt University · collabVirtua Medical Group · collabWake Forest University Health Sciences · collabWakeMed Health and Hospitals · collabWashington University School of Medicine · collabWeill Medical College of Cornell University · collabWinthrop University Hospital · collabWomen and Infants Hospital of Rhode Island · collabYale University · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate whether a blood pressure treatment strategy during pregnancy to achieve targets that are recommended for non-pregnant reproductive-age adults (\<140/90 mmHg) compared ACOG- recommended standard during pregnancy (no treatment unless BP is severe) is effective and safe.

Timeline

Start
2015-06
Primary completion
2022-04-01
Completion
2022-12-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Labetalol Small molecule Oral
Subject Nifedipine Other / unclassified Oral

Indications